1. Home
  2. MKL vs DGX Comparison

MKL vs DGX Comparison

Compare MKL & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Markel Group Inc.

MKL

Markel Group Inc.

HOLD

Current Price

$1,870.86

Market Cap

22.7B

Sector

Finance

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$190.42

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKL
DGX
Founded
1930
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.7B
23.1B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
MKL
DGX
Price
$1,870.86
$190.42
Analyst Decision
Hold
Buy
Analyst Count
1
13
Target Price
$2,100.00
$214.38
AVG Volume (30 Days)
74.9K
886.1K
Earning Date
04-28-2026
04-21-2026
Dividend Yield
N/A
1.82%
EPS Growth
N/A
13.78
EPS
N/A
2.24
Revenue
$15,513,233,000.00
$11,035,000,000.00
Revenue This Year
N/A
$7.53
Revenue Next Year
$2.26
$3.77
P/E Ratio
N/A
$84.78
Revenue Growth
N/A
11.78
52 Week Low
$1,719.41
$164.65
52 Week High
$2,207.59
$213.50

Technical Indicators

Market Signals
Indicator
MKL
DGX
Relative Strength Index (RSI) 51.74 45.08
Support Level $1,812.24 $186.91
Resistance Level $1,998.57 $191.91
Average True Range (ATR) 34.75 3.96
MACD 10.82 -0.09
Stochastic Oscillator 95.35 36.10

Price Performance

Historical Comparison
MKL
DGX

About MKL Markel Group Inc.

Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: